Travelers' preferences for tick-borne encephalitis vaccination

被引:2
作者
Poulos, Christine [1 ]
Boeri, Marco [2 ]
Coulter, Joshua [1 ]
Huang, Liping [3 ]
Schley, Katharina [4 ]
Pugh, Sarah J. [3 ]
机构
[1] RTI Hlth Solut, 3040 East Cornwallis Rd, Res Triangle Pk, NC 27709 USA
[2] RTI Hlth Solut, Belfast, Antrim, North Ireland
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Pharma GmbH, Berlin, Germany
关键词
Stated preferences; risk level; threshold technique; tick-borne encephalitis; tick-borne illness; DISCRETE-CHOICE EXPERIMENTS; PRIVATE DEMAND; VACCINES; CHOLERA;
D O I
10.1080/14760584.2022.2108798
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background This study aimed to quantify preferences and risk tolerance for a tick-borne encephalitis (TBE) vaccination. Research Design and Methods A stated-preference survey instrument was administered to international travelers living in the United States to elicit preferences for a no-cost TBE vaccine when planning an international trip, conditional upon four different qualitative levels of endemic TBE risk. Results The likelihood of choosing the vaccine increased with a destination's level of endemic risk. Most respondents (94%) would choose to receive the vaccine at the highest risk level presented in the survey (i.e. when multiple TBE cases among humans are reported year after year); 6% of the sample would choose not to receive the vaccine at any risk level. Respondents who engage in outdoor activities were twice as likely as the average respondent to choose vaccination rather than opting out of vaccination, and were one-third more likely than the average respondent to choose to receive the vaccine at the lowest risk level. Conclusions Respondents were highly interested in a TBE vaccine, assuming no cost, and most were willing to be vaccinated at all qualitative TBE risk levels. Respondents who participated in outdoor activities were more likely than the average respondent to choose the vaccine.
引用
收藏
页码:1495 / 1504
页数:10
相关论文
共 33 条
[1]  
[Anonymous], 2022, Tick-borne encephalitis (TBE)." from
[2]  
CDC, 2021, ACIP EV REC FRAM DEN
[3]  
CDC, 2019, JAPANESE ENCEPHALITI
[4]  
CDC, 2022, EV REC TBE VIR TRANS
[5]   Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments [J].
Diks, Marilyn Emma ;
Hiligsmann, Mickael ;
Van der Putten, Ingeborg Maria .
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[6]  
Erber W., 2019, TBE BOOK, V2nd, P212
[7]   Visualization of central European tick-borne encephalitis infection in fatal human cases [J].
Gelpi, E ;
Preusser, M ;
Garzuly, F ;
Holzmann, H ;
Heinz, FX ;
Budka, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (06) :506-512
[8]   Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue [J].
Gelpi, Ellen ;
Preusser, Matthias ;
Laggner, Ute ;
Garzuly, Ferenc ;
Holzmann, Heidemarie ;
Heinz, Franz Xaver ;
Budka, Herbert .
JOURNAL OF NEUROVIROLOGY, 2006, 12 (04) :322-327
[9]   Tick-borne encephalitis -: pathogenesis, clinical course and long-term follow-up [J].
Haglund, M ;
Günther, G .
VACCINE, 2003, 21 :S11-S18
[10]   Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force [J].
Hauber, A. Brett ;
Gonzalez, Juan Marcos ;
Groothuis-Oudshoorn, Catharina G. M. ;
Prior, Thomas ;
Marshall, Deborah A. ;
Cunningham, Charles ;
Ijzerman, Maarten J. ;
Bridges, John F. P. .
VALUE IN HEALTH, 2016, 19 (04) :300-315